CD4 and hypertensive disorder: More recently, it has been found that Tregs (CD4+CD25+FoxP3+) can act to limit Ang II–induced inflammation and damage in the vasculature and heart, thereby reducing the extent of hypertension and cardiac remodeling (36–40).